Market Overview

Artificial Intelligence in Life Sciences 2018-2023: Global Market is Expected to Grow at a CAGR of 30% - Clinical Trials to Provide Immense Opportunities - ResearchAndMarkets.com

Share:

The "Global
Artificial Intelligence in Life Sciences Market - Growth, Trend and
Forecasts (2018 - 2023)"
report has been added to ResearchAndMarkets.com's
offering.

Artificial intelligence in life sciences market is expected to grow at a
CAGR of over 30% during the forecast period (2018-2023).

With the advent of the third wave of AI, it is estimated that advanced
AI solutions in the current market scenario can learn and evolve as they
are being used. Further, the penetration of AI life sciences solutions
into the mobile application sector is expected to be the prime driver of
AI solutions in the near future.

While the tremendous demand for Artificial Intelligence in life sciences
applications such as drug discovery and patient monitoring are opening
up new opportunities, concerns over layoffs and unemployment and high
initial costs involved with AI technology could potentially restrain the
growth in the market.

Owing to high foreign investments in the pharmaceutical sector, Asia
Pacific countries are expected to witness the most substantial growth
for AI solutions over the forecast period.

Key Highlights

  • Clinical Trials to Provide Immense Opportunities
  • Asia-Pacific to be the Fastest Growing Market

Developments in the Market

  • February 2018 - Medtronic Plc., a prominent medical devices company
    based in Ireland, launched its AI-based Sugar.IQ diabetes management
    app, which is powered by IBM Watson Health. Watson is expected to
    provide capabilities to the app that evaluates user's blood sugar
    levels in response to variables such as food intake and insulin dosing

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Artificial Intelligence in Life Sciences Market Dynamics

5. Technology Snapshot

6. Global AI in Lifesciences Market - Segmentation

7. Competitive Intelligence - Key Vendor Profiles

  • IBM Corporation
  • AiCure, LLC
  • NuMedii, Inc.
  • twoXAR, Inc.
  • Atomwise Inc
  • Lifegraph Limited
  • Cyrcadia Health Inc
  • Zebra Medical Vision
  • APIXIO, Inc.
  • Enlitic, Inc.
  • Insilico Medicine, Inc.
  • Numerate, Inc.
  • Sophia Genetics SA
  • Sensely Inc.

8. Investment Scenrio

9. Market Outlook

For more information about this report visit https://www.researchandmarkets.com/research/d58tb2/artificial?w=4

View Comments and Join the Discussion!